β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (663) π οΈ Industry Q&A (164) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due DiligenceποΈ SEC Filings
| Date accepted | Link | Final link |
|---|---|---|
| 2026-06-11 07:58:11 | 6-K | 6-K final |
| 2026-04-28 06:21:18 | 6-K | 6-K final |
| 2026-03-18 16:23:38 | 6-K | 6-K final |
| 2026-03-17 16:40:53 | 424B5 | 424B5 final |
| 2026-03-16 19:23:19 | FWP | FWP final |
| 2026-03-16 08:16:48 | ***** | ***** |
| 2026-02-04 16:30:35 | ***** | ***** |
| 2026-02-04 06:52:05 | ***** | ***** |
| 2026-02-04 06:51:07 | ***** | ***** |
| 2026-02-04 06:50:01 | ***** | ***** |
| 2026-02-04 06:45:53 | ***** | ***** |
| 2026-01-16 16:45:45 | ***** | ***** |
| 2026-01-16 16:45:35 | ***** | ***** |
| 2026-01-16 16:45:18 | ***** | ***** |
| 2026-01-16 16:45:05 | ***** | ***** |
π Explore more SEC filings for Novartis!
Sign up for free or log inπ Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting